XTL6001
/ Shaanxi Micot Technology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 04, 2025
Phase I Study of XTL6001 Injection in Healthy and Obese Subjects
(clinicaltrials.gov)
- P1 | N=80 | Recruiting | Sponsor: Shanghai Xitaili Biomedicine Technology co., Ltd.
New P1 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1